Search

Your search keyword '"Maixnerova, Dita"' showing total 138 results

Search Constraints

Start Over You searched for: Author "Maixnerova, Dita" Remove constraint Author: "Maixnerova, Dita"
138 results on '"Maixnerova, Dita"'

Search Results

1. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

2. Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

3. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

4. Novel transcriptomic signatures associated with premature kidney allograft failure

5. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

6. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

7. Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis

10. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

13. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

14. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

16. Expanding options of supportive care in IgA nephropathy.

17. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

19. Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy.

20. Urine proteomics for prediction of disease progression in patients with IgA nephropathy

21. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis

24. GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

26. Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

27. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis

31. MO041URINE PROTEOMICS FOR PREDICTION OF DISEASE PROGRESSION IN PATIENTS WITH IGA NEPHROPATHY

32. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? : A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

33. Urine Proteomics for Prediction of Disease Progression in Patients with IgA Nephropathy

34. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

41. A NOVEL BIOMARKER OF TYPE VI COLLAGEN FORMATION MEASURED IN SERUM AND URINE OF PATIENTS WITH IgA NEPHROPATHY REFLECTS THE LEVEL OF FIBROSIS IN THE KIDNEYS:[Meeting Abstract}

42. A BIOMARKER OF COLLAGEN TYPE III DEGRADATION DECREASES WITH INCREASING FIBROSIS IN THE KIDNEY OF PATIENTS WITH IgA NEPHROPATHY:[Meeting Abstract]

43. Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

45. Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

46. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort

47. MO028PROGRESSIVE IGA NEPHPHROPATHY AND DEFECTIVE COMPLEMENT INHIBITOR CD46 MRNA EXPRESSION

48. MO041IMMUNOPROTEASOME PSMB8 MRNA EXPRESSION IS CORRELATED WITH ANNUAL LOSS OF GLOMERULAR FILTRATION RATE (EGFR SLOPE) IN IGAN PATIENTS ENROLLED IN VALIGA STUDY

49. Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011

Catalog

Books, media, physical & digital resources